SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)
Fetzima is a prescription drug approved by the Food and Drug Administration (FDA) to treat major depressive disorder. Fetzima is also known by its drug name, Levomilnacipran.
Fetzima is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Fetzima is believed to work by changing the balance of neurotransmitters in the brain.
How do I take it?
Fetzima is taken once daily.
Fetzima comes in extended-release capsule form.
The FDA-approved label for Fetzima lists common side effects including nausea, vomiting, constipation, sweating, erectile dysfunction, increased heart rate, and heart palpitations.
Rare but serious side effects listed for Fetzima include mania, worsening depression, suicidal thinking and behavior, abnormal bleeding, glaucoma, trouble urinating, and serotonin syndrome, which can be fatal.
For more details about this treatment, visit:
Fetzima – Allergan